한글목차

착상전 유전자 진단의 동향과 예측

착상전 유전자 진단 세계 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 10.7%를 나타낼 전망이며, 2030년에는 2억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 유전성 질환의 유병률 증가, 생식 의료에서 유전학의 역할에 대한 의식 증가, 불임 치료에서 기술의 진보입니다. 착상전 유전자 진단 세계 시장은 진단 실험실, 병원, 클리닉 시장에서 비즈니스 기회가 있으며 미래가 기대됩니다.

착상전 유전자 진단 시장 인사이트

• Lucintel의 예측은 이수성 스크리닝법의 채용이 증가하고 신제품이 시장에 도입되기 때문에 예측 기간 동안 이수성이 가장 높은 성장을 이룰 전망입니다.
• 병원은 환자 입원 증가, 의료 인프라 개선, 공립 병원뿐만 아니라 사립 병원도이 지역에 있기 때문에 가장 큰 부문로 계속 될 것으로 보입니다.
• APAC은 체외수정(IVF)의 도입이 증가하고 있으며, 이 지역의 사람들의 체외수정(IVF)에 대한 의식이 높아짐에 따라 예측 기간 동안 가장 높은 성장이 예상됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장하는지, 그리고 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 착상전 유전자 진단 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 착상전 유전자 진단 동향(2018-2023년)과 예측(2024-2030년)
• 유형별 세계의 착상전 유전자 진단
  • 염색체 이상
  • 이수성
  • X 관련 질환
  • 단일 유전자 질환
  • HLA의 타이핑
  • 성별 선택
  • 기타
• 최종 용도별 세계의 착상전 유전자 진단 시장
  • 진단 실험실
  • 병원
  • 클리닉
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 착상전 유전자 진단
• 북미의 착상전 유전자 진단
• 유럽의 착상전 유전자 진단
• 아시아태평양의 착상전 유전자 진단
• 기타 지역 착상전 유전자 진단

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 착상전 유전자 진단 시장의 성장 기회
  • 최종 용도별 세계의 착상전 유전자 진단 시장의 성장 기회
  • 지역별 세계의 착상전 유전자 진단 시장의 성장 기회
• 세계의 착상전 유전자 진단 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 착상전 유전자 진단 시장의 능력 확대
  • 세계의 착상전 유전자 진단 시장에 있어서의 합병, 인수, 합작 사업
  • 인증 및 라이센스

제7장 유력 기업의 기업 프로파일

• PerkinElmer Agilent Technologies
• Cegat
• Laboratory Corporation of America Holdings
• Illumina
• Invitae Corporation
• Pacgenomics
• Quest Diagnostics
• Natera
• Reproductive Genetic Innovations(RGI)

영문목차

Preimplantation Genetics Diagnosis Trends and Forecast

The future of the global preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets. The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030 with a CAGR of 10.7% from 2024 to 2030. The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

A more than 150-page report is developed to help in your business decisions.

Preimplantation Genetics Diagnosis by Segment

The study includes a forecast for the global preimplantation genetics diagnosis by type, end use, and region.

Preimplantation Genetics Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Chromosomal Abnormalities
• Aneuploidy
• X-linked diseases
• Single Gene Disorders
• HLA Typing
• Gender selection
• Others

Preimplantation Genetics Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostic Laboratories
• Hospitals
• Clinics
• Others

Preimplantation Genetics Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Preimplantation Genetics Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preimplantation genetics diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preimplantation genetics diagnosis companies profiled in this report include-

• Perkinelmer Agilent Technologies
• Cegat
• Laboratory Corporation Of America Holdings
• Illumina
• Invitae Corporation
• Pacgenomics
• Quest Diagnostics
• Natera
• Reproductive Genetic Innovations (Rgi)

Preimplantation Genetics Diagnosis Market Insights

• Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.

• Hospitals will remain the largest segment due to increasing admissions of patients, improvement in healthcare infrastructure, and availability of public as well as private hospitals in the region.

• APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Features of the Global Preimplantation Genetics Diagnosis Market

• Market Size Estimates: Preimplantation genetics diagnosis market size estimation in terms of value ($B).

• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

• Segmentation Analysis: Preimplantation genetics diagnosis market size by type, end use, and region. in terms of value ($B).

• Regional Analysis: Preimplantation genetics diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

• Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the preimplantation genetics diagnosis market.

• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preimplantation genetics diagnosis market.

• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the preimplantation genetics diagnosis market size?

Answer: The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030.

Q.2. What is the growth forecast for preimplantation genetics diagnosis market?

Answer: The global preimplantation genetics diagnosis market is expected to grow with a CAGR of 10.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the preimplantation genetics diagnosis market?

Answer: The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

Q.4. What are the major segments for preimplantation genetics diagnosis market?

Answer: The future of the preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets.

Q.5. Who are the key Preimplantation Genetics Diagnosis Market companies?

Answer: Some of the key preimplantation genetics diagnosis companies are as follows:

• PerkinElmer Agilent Technologies
• Cegat
• Laboratory Corporation of America Holdings
• Illumina
• Invitae Corporation
• Pacgenomics
• Quest Diagnostics
• Natera
• Reproductive Genetic Innovations (RGI)

Q.6. Which preimplantation genetics diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.

Q.7. In preimplantation genetics diagnosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the preimplantation genetics diagnosis market by type (chromosomal abnormalities, aneuploidy, X-linked diseases,single gene disorders, HLA typing, gender selection, and others), end use (diagnostic laboratories, hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preimplantation Genetics Diagnosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Preimplantation Genetics Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Preimplantation Genetics Diagnosis Market by Type
  • 3.3.1: Chromosomal Abnormalities
  • 3.3.2: Aneuploidy
  • 3.3.3: X-linked Diseases
  • 3.3.4: Single Gene Disorders
  • 3.3.5: HLA Typing
  • 3.3.6: Gender Selection
  • 3.3.7: Others
• 3.4: Global Preimplantation Genetics Diagnosis Market by End Use
  • 3.4.1: Diagnostic Laboratories
  • 3.4.2: Hospitals
  • 3.4.3: Clinics
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Preimplantation Genetics Diagnosis Market by Region
• 4.2: North American Preimplantation Genetics Diagnosis Market
  • 4.2.2: North American Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
• 4.3: European Preimplantation Genetics Diagnosis Market
  • 4.3.1: European Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
  • 4.3.2: European Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
• 4.4: APAC Preimplantation Genetics Diagnosis Market
  • 4.4.1: APAC Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
  • 4.4.2: APAC Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
• 4.5: ROW Preimplantation Genetics Diagnosis Market
  • 4.5.1: ROW Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
  • 4.5.2: ROW Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by Type
  • 6.1.2: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by End Use
  • 6.1.3: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by Region
• 6.2: Emerging Trends in the Global Preimplantation Genetics Diagnosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Preimplantation Genetics Diagnosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preimplantation Genetics Diagnosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PerkinElmer Agilent Technologies
• 7.2: Cegat
• 7.3: Laboratory Corporation of America Holdings
• 7.4: Illumina
• 7.5: Invitae Corporation
• 7.6: Pacgenomics
• 7.7: Quest Diagnostics
• 7.8: Natera
• 7.9: Reproductive Genetic Innovations (RGI)